International Assets Investment Management LLC Acquires Shares of 84,198 Dolby Laboratories, Inc. (NYSE:DLB)

International Assets Investment Management LLC bought a new position in shares of Dolby Laboratories, Inc. (NYSE:DLB - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 84,198 shares of the electronics maker's stock, valued at approximately $7,256,000. International Assets Investment Management LLC owned 0.09% of Dolby Laboratories at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in Dolby Laboratories by 3.3% during the 3rd quarter. Vanguard Group Inc. now owns 6,389,084 shares of the electronics maker's stock worth $506,399,000 after acquiring an additional 205,319 shares during the period. Kayne Anderson Rudnick Investment Management LLC boosted its holdings in shares of Dolby Laboratories by 3.0% in the 1st quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,265,758 shares of the electronics maker's stock valued at $449,801,000 after purchasing an additional 154,954 shares in the last quarter. Morgan Stanley boosted its holdings in shares of Dolby Laboratories by 11.9% in the 3rd quarter. Morgan Stanley now owns 4,902,295 shares of the electronics maker's stock valued at $388,556,000 after purchasing an additional 523,250 shares in the last quarter. BlackRock Inc. boosted its holdings in shares of Dolby Laboratories by 1.6% in the 2nd quarter. BlackRock Inc. now owns 3,167,627 shares of the electronics maker's stock valued at $265,067,000 after purchasing an additional 48,773 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its holdings in shares of Dolby Laboratories by 12.5% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,884,088 shares of the electronics maker's stock valued at $149,333,000 after purchasing an additional 209,369 shares in the last quarter. Institutional investors own 58.56% of the company's stock.

Insiders Place Their Bets

In other Dolby Laboratories news, SVP John D. Couling sold 33,560 shares of Dolby Laboratories stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $80.81, for a total transaction of $2,711,983.60. Following the transaction, the senior vice president now directly owns 108,519 shares of the company's stock, valued at approximately $8,769,420.39. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO Kevin J. Yeaman sold 9,030 shares of Dolby Laboratories stock in a transaction dated Wednesday, January 17th. The stock was sold at an average price of $83.51, for a total value of $754,095.30. Following the completion of the transaction, the chief executive officer now directly owns 83,721 shares of the company's stock, valued at approximately $6,991,540.71. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP John D. Couling sold 33,560 shares of Dolby Laboratories stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $80.81, for a total value of $2,711,983.60. Following the completion of the transaction, the senior vice president now directly owns 108,519 shares of the company's stock, valued at $8,769,420.39. The disclosure for this sale can be found here. Company insiders own 39.54% of the company's stock.

Dolby Laboratories Price Performance

Shares of NYSE DLB traded down $1.58 during mid-day trading on Monday, hitting $78.61. 314,200 shares of the stock traded hands, compared to its average volume of 378,325. Dolby Laboratories, Inc. has a twelve month low of $75.87 and a twelve month high of $91.01. The company has a market cap of $7.51 billion, a PE ratio of 40.73 and a beta of 0.97. The firm has a 50 day simple moving average of $81.71 and a two-hundred day simple moving average of $83.41.

Dolby Laboratories (NYSE:DLB - Get Free Report) last released its quarterly earnings data on Thursday, February 1st. The electronics maker reported $0.76 earnings per share for the quarter, beating the consensus estimate of $0.62 by $0.14. Dolby Laboratories had a return on equity of 10.21% and a net margin of 14.70%. The company had revenue of $315.57 million for the quarter, compared to the consensus estimate of $310.98 million. On average, equities research analysts anticipate that Dolby Laboratories, Inc. will post 2.63 earnings per share for the current fiscal year.

Dolby Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, February 22nd. Shareholders of record on Tuesday, February 13th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.53%. The ex-dividend date was Monday, February 12th. Dolby Laboratories's payout ratio is presently 62.18%.

Wall Street Analysts Forecast Growth

DLB has been the topic of a number of research analyst reports. StockNews.com raised Dolby Laboratories from a "hold" rating to a "buy" rating in a report on Friday, February 2nd. Rosenblatt Securities reaffirmed a "buy" rating and issued a $98.00 target price on shares of Dolby Laboratories in a report on Wednesday, January 31st.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.